Last updated 2026-08-18
- Raised $9M B Round Extension, 1999
- Raised $7M Series A led by Denali Ventures
- Raised $2M Series B led by Medica Venture Partners, 1997
Total raised
$18.0M
Stage
—
Founded
1996
Headcount
—
HQ
Petach Tikva, Israel
Sector
Pharmaceuticals
About
Collgard Biopharmaceuticals develops unique therapeutic products that affect the turnover of collagen to prevent or treat scleroderma, solid tumors, restenosis, and other fibrotic disorders. The company focuses on developing drug treatments that directly impact the tissue regeneration process to target disease progression. Their versatile lead compound is halofuginone, which appears to specifically block the production of collagen type 1.
Funding history · 3 rounds · $18.0M total
1999
B Round Extension
$9.0M
1997
B Round
$2.0M
★ Medica Venture Partners
Date unknown
A Round
$7.0M
★ Denali Ventures★ Medica Venture Partners
Team · 1
Neal Farber
Founder · CEO
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1996 |
|---|
Acquisitions & public offerings
Acquired by 2011-03